Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Non-cash Items (2016 - 2018)

Historic Non-cash Items for Amicus Therapeutics (FOLD) over the last 9 years, with Q1 2018 value amounting to $8.6 million.

  • Amicus Therapeutics' Non-cash Items fell 7675.19% to $8.6 million in Q1 2018 from the same period last year, while for Mar 2018 it was $8.6 million, marking a year-over-year decrease of 7675.19%. This contributed to the annual value of $8.0 million for FY2017, which is 7630.39% down from last year.
  • Per Amicus Therapeutics' latest filing, its Non-cash Items stood at $8.6 million for Q1 2018, which was down 7675.19% from $8.0 million recorded in Q4 2017.
  • In the past 5 years, Amicus Therapeutics' Non-cash Items registered a high of $37.2 million during Q1 2017, and its lowest value of $5.3 million during Q3 2015.
  • Its 5-year average for Non-cash Items is $14.8 million, with a median of $8.3 million in 2017.
  • As far as peak fluctuations go, Amicus Therapeutics' Non-cash Items surged by 50402.31% in 2016, and later plummeted by 7675.19% in 2018.
  • Amicus Therapeutics' Non-cash Items (Quarter) stood at $5.4 million in 2014, then fell by 2.66% to $5.3 million in 2015, then skyrocketed by 535.51% to $33.7 million in 2016, then crashed by 76.3% to $8.0 million in 2017, then increased by 8.3% to $8.6 million in 2018.
  • Its Non-cash Items was $8.6 million in Q1 2018, compared to $8.0 million in Q4 2017 and $8.7 million in Q3 2017.